ARIHANTACA vs ENTERO: Stock Comparison
ENTERO HEALTHCARE SOLU L is the larger company by market capitalisation. ARIHANTACA shows a lower P/E, a higher ROE and lower leverage, while ENTERO HEALTHCARE SOLU L shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ARIHANTACA leads 5; ENTERO leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ARIHANTACA | ENTERO |
|---|---|---|
| Sector | — | Consumer Services |
| Industry | — | Pharmacy Retail |
Price
| Metric | ARIHANTACA | ENTERO |
|---|---|---|
| Live Price | — | ₹1,732.3 |
| Day Change | — | 3.94% |
| Volume | — | 2.45 L |
| 52-Week High | — | ₹1,920 |
| 52-Week Low | — | ₹944 |
| Distance from 52W High | — | -9.78% |
Valuation
| Metric | ARIHANTACA | ENTERO |
|---|---|---|
| Market Cap | ₹303 Cr | ₹7,508 Cr |
| P/E Ratio | 30.92x | 59.85x |
| P/B Ratio | 9.7x | 4.44x |
| EPS | ₹3.39 | ₹8.77 |
| Book Value | ₹55.39 | ₹402.67 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | ARIHANTACA | ENTERO |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 42.6% |
| EPS Growth (TTM YoY) | 0% | 9.1% |
| Qtr Sales Growth | 10.95% | 2,230.48% |
| Qtr Profit Growth | 6.55% | 1,405.67% |
Profitability & Leverage
| Metric | ARIHANTACA | ENTERO |
|---|---|---|
| ROE | 27.15% | 8.32% |
| ROCE | 32.04% | 8.38% |
| Net Margin | 0% | 1.75% |
| Operating Margin | 19.7% | 3.55% |
| Debt to Equity | 0x | 0.32x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | ARIHANTACA | ENTERO |
|---|---|---|
| Promoter Holding | 64.74% | 14.4%▼ 0.01 pp |
| FII Holding | 0% | 4.37%▲ 0.34 pp |
| DII Holding | 0% | 15.48%▼ 1.14 pp |
| Public Holding | 35.26% | 27.75%▲ 0.82 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ARIHANTACA and ENTERO HEALTHCARE SOLU L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.